Top Markets
Coin of the day
BioSenic S.A. BioSenic S.A.

BioSenic S.A.

BIOS
Rank in Stocks #37641
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium,... BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
Share Price
$0.00237231
Last synced: 2026-06-22
Market Cap
$1.55M
Change (1 day)
0.00%
Change (1 year)
-18.94%
Country
BE
Trade BioSenic S.A. (BIOS)

Category

P/B ratio for BioSenic S.A. (BIOS)
P/B ratio as of 2026 TTM: 0
According to BioSenic S.A. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for BioSenic S.A. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.2613 -
US
6.3483 -
NL
- -
CH
- -
KR
3.634 -
BE